- Published: December 13, 2021
- Updated: December 13, 2021
- University / College: University of Vermont
- Language: English
- Downloads: 27
A Corrigendum on
Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases
by Zgheib, E., Limonciel, A., Jiang, X., Wilmes, A., Wink, S., van de Water, B., et al. (2018). Front. Genet. 9: 429. doi: 10. 3389/fgene. 2018. 00429
In the original article, we neglected to mention that this work was partly supported by the EU-ToxRisk project (An Integrated European “ Flagship” Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002).
A correction has therefore been made to theAcknowledgments:
“ The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (IMIJU) under grant agreement number 115439, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. This work was supported by the 2015 CEFIC-LRI award (AL) and partly supported by the EU-ToxRisk project (An Integrated European “ Flagship” Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002). This publication reflects only the author’s views and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
